UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045074
Receipt number R000051495
Scientific Title A prospective cohort study of taste changes due to weight loss in highly obese patients
Date of disclosure of the study information 2021/08/06
Last modified on 2022/12/22 16:29:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective cohort study of taste changes due to weight loss in highly obese patients

Acronym

A study for taste change in obese patients

Scientific Title

A prospective cohort study of taste changes due to weight loss in highly obese patients

Scientific Title:Acronym

A study for taste change in obese patients

Region

Japan


Condition

Condition

Obesity

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effect of weight loss on taste (fat taste, umami, sweetness) in severely obese patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Taste rank

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

Non-obese patients (BMI less than 25) or highly obese patients (BMI over 30) who are outpatients and hospitalized in the Department of Diabetes and Endocrinology and Metabolism, Wakayama Prefectural Medical University Hospital, and who have consented to the study.

Key exclusion criteria

1. Patients with a history of severe ketosis or diabetic coma within 6 weeks of the start of the study
2. Patients who develop severe hypoglycemia within 6 weeks of the start of the study
3. Patients with severe renal dysfunction (eGFR <15 mL / min / 1.73 m2) or patients with end-stage renal disease on dialysis
4. Patients with proliferative retinopathy (excluding patients who have undergone photocoagulation and have stable state)
5. Patients with severe gastrointestinal disorders within 2 weeks of the study
6. Pregnant or potentially pregnant women and lactating patients
7. Patients with severe infections and serious trauma
8. Patients with other serious food allergies, including dairy products
9. Other patients who the principal investigator deems inappropriate as subjects

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Akiko
Middle name
Last name Tanaka

Organization

Wakayama Medical University Hospital

Division name

Division of Clinical Nutrition and Metabolism

Zip code

641-8510

Address

811-1 Kimiidera Wakayama city Wakayama Prefecture

TEL

0734410513

Email

atanaka@wakayama-med.ac.jp


Public contact

Name of contact person

1st name Akiko
Middle name
Last name Tanaka

Organization

Wakayama Medical University Hospital

Division name

Division of Clinical Nutrition and Metabolism

Zip code

641-8510

Address

811-1 Kimiidera Wakayama city Wakayama Prefecture

TEL

0734410513

Homepage URL


Email

atanaka@wakayama-med.ac.jp


Sponsor or person

Institute

Wakayama Medical University Hospital

Institute

Department

Personal name



Funding Source

Organization

Wakayama Medical University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee of Wakayama Medical University

Address

811-1 Kimiidera Wakayama city Wakayama Prefecture

Tel

0734472300

Email

wa-rinri@wakayama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 08 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

26

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 01 Month 23 Day

Date of IRB

2020 Year 01 Month 23 Day

Anticipated trial start date

2020 Year 01 Month 23 Day

Last follow-up date

2022 Year 08 Month 19 Day

Date of closure to data entry

2022 Year 08 Month 19 Day

Date trial data considered complete

2022 Year 08 Month 19 Day

Date analysis concluded

2022 Year 08 Month 19 Day


Other

Other related information

Questionnaire


Management information

Registered date

2021 Year 08 Month 05 Day

Last modified on

2022 Year 12 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051495


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name